PROphet
®
PROphetNSCLC
TM
Test
PROphet
®
Technology
Resources
For Patients
For Providers
For Pharma
Science
Publications
Presentations
Clinical studies
Collaborators
About Us
News
In the news
Thought Leadership
Press releases
Meetings & Events
Awards
Contact Us
Careers
US openings
Israel openings
Order a test
PROphet
®
PROphetNSCLC
TM
Test
PROphet
®
Technology
Resources
For Patients
For Providers
For Pharma
Science
Publications
Presentations
Clinical Studies
Collaborators
News
In the News
Thought Leadership
Press Releases
Meetings & Events
Awards
Company
About us
Careers
Contact us
Order a test
In the News
Thought Leadership
Press Releases
Meetings & Events
Awards
January 19, 2021
OncoHost Raises $8 Million in Series B Funding Round
Original source
here.
Recent news
August 16, 2024
OncoHost announces three abstracts selected for presentation at WCLC 2024
Read more
August 5, 2024
Clinical Lung Cancer publishes study: 93% of oncologists adjust treatment recommendations with OncoHost’s PROphetNSCLC test
Read more
August 2, 2024
Ninety-three percent of oncologists adjust treatment recommendations with OncoHost’s PROphetNSCLC test
Read more
July 30, 2024
Matching Patients with Treatments: Developing Clinically Meaningful Diagnostics To Inform Cancer-Immunotherapy Selection
Read more
July 29, 2024
New Test Influences First-Line Therapy Decisions for Metastatic NSCLC Patients
Read more
June 18, 2024
OncoHost: Finding New, Better Immunotherapies for Complex Cancers
Read more
Read all news